HUP0402671A3 - Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments - Google Patents

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Info

Publication number
HUP0402671A3
HUP0402671A3 HU0402671A HUP0402671A HUP0402671A3 HU P0402671 A3 HUP0402671 A3 HU P0402671A3 HU 0402671 A HU0402671 A HU 0402671A HU P0402671 A HUP0402671 A HU P0402671A HU P0402671 A3 HUP0402671 A3 HU P0402671A3
Authority
HU
Hungary
Prior art keywords
oxadiazol
medicaments
alkoxy
ones
phenyl
Prior art date
Application number
HU0402671A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HUP0402671A2 publication Critical patent/HUP0402671A2/hu
Publication of HUP0402671A3 publication Critical patent/HUP0402671A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
HU0402671A 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments HUP0402671A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
PCT/EP2003/001484 WO2003072555A1 (de) 2002-02-28 2003-02-14 Substituierte 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-one sowie ihre herstellung und verwendung in arzneistoffen

Publications (2)

Publication Number Publication Date
HUP0402671A2 HUP0402671A2 (hu) 2005-04-28
HUP0402671A3 true HUP0402671A3 (en) 2006-07-28

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402671A HUP0402671A3 (en) 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (https=)
JP (1) JP4486363B2 (https=)
KR (1) KR20040095240A (https=)
CN (1) CN1639137A (https=)
AR (1) AR038701A1 (https=)
AT (1) ATE557012T1 (https=)
AU (1) AU2003226977A1 (https=)
BR (1) BR0307921A (https=)
CA (1) CA2477031A1 (https=)
CO (1) CO5611146A2 (https=)
DE (1) DE10208987A1 (https=)
HR (1) HRP20040782A2 (https=)
HU (1) HUP0402671A3 (https=)
IL (1) IL163683A0 (https=)
MA (1) MA27172A1 (https=)
MX (1) MXPA04007960A (https=)
NO (1) NO20044090L (https=)
PE (1) PE20030928A1 (https=)
PL (1) PL370423A1 (https=)
RU (1) RU2004128933A (https=)
TW (1) TW200400951A (https=)
WO (1) WO2003072555A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
JP2008517976A (ja) 2004-10-25 2008-05-29 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb1カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病1型、肥満及び関連症状の治療用の医薬組成物
JP2011507952A (ja) * 2007-12-27 2011-03-10 バイアル−ポルテラ アンド シーエー,エス.エー. 医療用途用5−o−置換3−n−フェニル−1、3、4−オキサジアゾロン類
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
TR200401217T4 (tr) * 2000-03-07 2004-06-21 Aventis Pharma Deutschland Gmbh İkameli 3-Fenil-5-Alkoksi-1,3,4-Oksdiazol-2-one (ve) hormona duyarlı lipazın önlenmesinde kullanılması

Also Published As

Publication number Publication date
TW200400951A (en) 2004-01-16
AU2003226977A1 (en) 2003-09-09
BR0307921A (pt) 2004-12-21
CA2477031A1 (en) 2003-09-04
IL163683A0 (en) 2005-12-18
ATE557012T1 (de) 2012-05-15
JP2005519085A (ja) 2005-06-30
MXPA04007960A (es) 2004-11-26
EP1480960A1 (de) 2004-12-01
AR038701A1 (es) 2005-01-26
WO2003072555A1 (de) 2003-09-04
JP4486363B2 (ja) 2010-06-23
MA27172A1 (fr) 2005-01-03
PL370423A1 (en) 2005-05-30
NO20044090L (no) 2004-11-04
CN1639137A (zh) 2005-07-13
EP1480960B1 (de) 2012-05-09
PE20030928A1 (es) 2003-12-17
DE10208987A1 (de) 2003-09-11
CO5611146A2 (es) 2006-02-28
RU2004128933A (ru) 2005-04-20
HRP20040782A2 (en) 2005-02-28
HUP0402671A2 (hu) 2005-04-28
KR20040095240A (ko) 2004-11-12

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
HUP0104917A3 (en) Azepinoindole derivatives, the production and use thereof
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
IL142917A0 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
HRPK20010007B1 (en) Benzimidazoles, production thereof and use thereof as medicaments
IL142096A0 (en) Indeno-, naphtho-and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
IL149400A0 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
ZA200604432B (en) Thiozolidinones production and use thereof as medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
HUP0402671A3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
MXPA03006580A (es) Amidas de acido carboxilico, su produccion y su uso como medicamentos.
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees